Search

Howard J Sanders

Examiner (ID: 15220, Phone: (571)270-3096 , Office: P/3653 )

Most Active Art Unit
3653
Art Unit(s)
3658, 3653
Total Applications
914
Issued Applications
683
Pending Applications
65
Abandoned Applications
166

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18351255 [patent_doc_number] => 20230139366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => BRARTEMICIN ANALOGUES [patent_app_type] => utility [patent_app_number] => 18/047708 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27175 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047708 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/047708
BRARTEMICIN ANALOGUES Oct 18, 2022 Pending
Array ( [id] => 18162015 [patent_doc_number] => 20230028607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA [patent_app_type] => utility [patent_app_number] => 17/960966 [patent_app_country] => US [patent_app_date] => 2022-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960966 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/960966
COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA Oct 5, 2022 Pending
Array ( [id] => 18339918 [patent_doc_number] => 20230131867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => TRITERPENE SAPONINS, METHODS OF SYNTHESIS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/947716 [patent_app_country] => US [patent_app_date] => 2022-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38692 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947716 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/947716
TRITERPENE SAPONINS, METHODS OF SYNTHESIS AND USES THEREOF Sep 18, 2022 Pending
Array ( [id] => 18518506 [patent_doc_number] => 11708386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root [patent_app_type] => utility [patent_app_number] => 17/946531 [patent_app_country] => US [patent_app_date] => 2022-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4005 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946531 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/946531
Ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root Sep 15, 2022 Issued
Array ( [id] => 18254107 [patent_doc_number] => 20230081146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS [patent_app_type] => utility [patent_app_number] => 17/931491 [patent_app_country] => US [patent_app_date] => 2022-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/931491
METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS Sep 11, 2022 Pending
Array ( [id] => 18299334 [patent_doc_number] => 20230109020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes [patent_app_type] => utility [patent_app_number] => 17/941835 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21955 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941835 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/941835
Nucleic Acid and Other Compositions and Methods for the Modulation of Cell Membranes Sep 8, 2022 Pending
Array ( [id] => 18034522 [patent_doc_number] => 20220378737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS [patent_app_type] => utility [patent_app_number] => 17/873638 [patent_app_country] => US [patent_app_date] => 2022-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873638 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/873638
TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS Jul 25, 2022 Pending
Array ( [id] => 18177133 [patent_doc_number] => 20230037862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => SYNTHETIC AGONISTS OF TLR4 RECEPTOR [patent_app_type] => utility [patent_app_number] => 17/813140 [patent_app_country] => US [patent_app_date] => 2022-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7478 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813140 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/813140
SYNTHETIC AGONISTS OF TLR4 RECEPTOR Jul 17, 2022 Pending
Array ( [id] => 18125056 [patent_doc_number] => 20230010671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-12 [patent_title] => PROTON ACTIVATED ATOMIC MEDICINE [patent_app_type] => utility [patent_app_number] => 17/850467 [patent_app_country] => US [patent_app_date] => 2022-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18538 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850467 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/850467
PROTON ACTIVATED ATOMIC MEDICINE Jun 26, 2022 Pending
Array ( [id] => 17851812 [patent_doc_number] => 20220281854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => COMBINATION THERAPY FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/751153 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751153 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/751153
COMBINATION THERAPY FOR TREATING CANCER May 22, 2022 Pending
Array ( [id] => 17790445 [patent_doc_number] => 20220249536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => ANTIBODY DRUG CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/730924 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730924 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/730924
Antibody drug conjugates Apr 26, 2022 Issued
Array ( [id] => 17807418 [patent_doc_number] => 20220259253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => CD73 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/722513 [patent_app_country] => US [patent_app_date] => 2022-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74599 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -123 [patent_words_short_claim] => 1087 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722513 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/722513
CD73 INHIBITORS Apr 17, 2022 Pending
Array ( [id] => 17944333 [patent_doc_number] => 20220331350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => METHODS FOR TREATMENT AND PROPHYLAXIS OF HIV AND AIDS [patent_app_type] => utility [patent_app_number] => 17/658547 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658547 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/658547
METHODS FOR TREATMENT AND PROPHYLAXIS OF HIV AND AIDS Apr 7, 2022 Pending
Array ( [id] => 17670944 [patent_doc_number] => 20220184111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY [patent_app_type] => utility [patent_app_number] => 17/682655 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682655 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/682655
METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY Feb 27, 2022 Pending
Array ( [id] => 18109631 [patent_doc_number] => 20230002511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => HIGH-VISCOSITY LITHIUM CARBOXYMETHYL CELLULOSE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/681971 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681971 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681971
High-viscosity lithium carboxymethyl cellulose and preparation method therefor and application thereof Feb 27, 2022 Issued
Array ( [id] => 17687687 [patent_doc_number] => 20220194979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => METHOD FOR PREPARING DELPHINIUM ACYLATED ANTHOCYANIN [patent_app_type] => utility [patent_app_number] => 17/674860 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4226 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 346 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674860 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674860
Method for preparing delphinium acylated anthocyanin Feb 17, 2022 Issued
Array ( [id] => 18091303 [patent_doc_number] => 20220409644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/674032 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50421 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674032
ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE Feb 16, 2022 Pending
Array ( [id] => 17642270 [patent_doc_number] => 20220170008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME [patent_app_type] => utility [patent_app_number] => 17/674177 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13472 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674177 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674177
POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME Feb 16, 2022 Pending
Array ( [id] => 17897108 [patent_doc_number] => 20220306770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => USE OF POLY ALPHA-1,3-GLUCAN ETHERS AS VISCOSITY MODIFIERS [patent_app_type] => utility [patent_app_number] => 17/667707 [patent_app_country] => US [patent_app_date] => 2022-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35958 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667707 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/667707
USE OF POLY ALPHA-1,3-GLUCAN ETHERS AS VISCOSITY MODIFIERS Feb 8, 2022 Pending
Array ( [id] => 17865361 [patent_doc_number] => 20220288096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER [patent_app_type] => utility [patent_app_number] => 17/588507 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10962 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588507 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/588507
COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER Jan 30, 2022 Pending
Menu